NMS-CNT

Biocompatability of carbon nanoparticles with tissues of the neuromuscular system

Coordinatore	UNIVERSITY OF BRIGHTON    more  Organization address address: "Lewes Road, Mithras House" city: BRIGHTON postcode: BN2 4AT contact info Titolo: Dr. Nome: Jimi Cognome: Adu Email: send email Telefono: -645139 Fax: -643903
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	633˙648 €
EC contributo	633˙648 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-IAPP-2008
Funding Scheme	MC-IAPP
Anno di inizio	2009
Periodo (anno-mese-giorno)	2009-05-01   -   2013-04-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITY OF BRIGHTON  Organization address address: "Lewes Road, Mithras House" city: BRIGHTON postcode: BN2 4AT contact info Titolo: Dr. Nome: Jimi Cognome: Adu Email: send email Telefono: -645139 Fax: -643903	UK (BRIGHTON)	coordinator	97˙184.00
2	Pharmidex Pharmaceutical Services Limited  Organization address address: HANOVER STREET 14 FLOOR 3 city: LONDON postcode: W1S 1RR contact info Titolo: Dr. Nome: Mohammad S. Cognome: Alavijeh Email: send email Telefono: -2406804 Fax: -1260387	UK (LONDON)	participant	351˙923.00
3	AKADEMIA GORNICZO-HUTNICZA IM. STANISLAWA STASZICA W KRAKOWIE  Organization address address: AL ADAMA MICKIEWICZA 30 city: KRAKOW postcode: 30-059 contact info Titolo: Prof. Nome: Stanislaw Cognome: Blazewicz Email: send email Telefono: +48 (0) 12-617-2239	PL (KRAKOW)	participant	184˙541.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The partners wish to build a long-term European, industry-academia consortium, to work on the problem of repairing tissue damage in the neuromuscular system (NS). We initially seek to determine the biocompatibility of carbon nanoparticles with tissues of the NS as an essential prelude to our medium to long-term goal of developing marketable novel carbon nanotube-based implants for tissue repair of the NS. Presently, there is no satisfactory method for repairing extensive damage of the different tissues of the NS namely, nerves, muscles, ligaments and tendons. In the case of nerve lesions, the major problem associated with most of the recently developed implants is their limited capacity for organising regenerating axons appropriately for functional tissue re-innervation. We believe that CNTs due to their unique combination of physico-chemical properties could play a major role in overcoming these problems and therefore enhance tissue integration and nerve repair. In the case of damaged skeletal muscles and tendons, we envisage that CNTs could play a key role in strengthening and repair of these types of NS tissues.'